Commercial influence and covid-19

Ray Moynihan, Helen Macdonald, Lisa Bero, Fiona Godlee

Research output: Contribution to journalEditorialResearch

Abstract

[Extract] Although the covid-19 pandemic has provoked the best of human compassion, the hallmarks of unhealthy commercial influence have also emerged. This week, The BMJ published the initial list of signatories to our call for action to reduce commercial influence in how healthcare evidence is produced and used (www.bmj.com/commercial-influence-call-to-action). Signatories include professors, patient advocates, clinicians, and researchers who want to see product evaluation, medical education, and clinical practice much freer from commercial interests.
Original languageEnglish
Article numberm2456
Number of pages2
JournalBMJ (Clinical research ed.)
Volume369
DOIs
Publication statusPublished - 24 Jun 2020

Fingerprint Dive into the research topics of 'Commercial influence and covid-19'. Together they form a unique fingerprint.

Cite this